UChicago Grants InFlectis BioScience Exclusive Rights to a Potential New Class of Therapies for Neuromuscular Diseases

The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has granted InFlectis BioScience rights to use a patented family of small molecules for the treatment of neuromuscular diseases. Per…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.